To understand this, the CRISPR-Cas9 system was utilized for genome editing to make ESR1 a single allele at mutated amino acid residue, tyrosine 537 in ER-sensitive MCF7- BC cell line [89]. The gene discussed is ESR1; the disease is breast cancer.